Intracochlear Injection of Glucocorticoid

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

August 25, 2025

Primary Completion Date

August 1, 2027

Study Completion Date

August 1, 2027

Conditions
Sudden Sensorineural Hearing Loss (SSNHL)
Interventions
DRUG

intracochlear triamcinolone acetonide injection

intracochlear triamcinolone acetonide injection of through the round window membrane

DRUG

intracochlear injection of dexamethasone through the round window membrane

intracochlear injection of dexamethasone sodium phosphate through the round window membrane

DRUG

intracochlear dexamethasone injection and intratympanic dexamethasone injection

intracochlear dexamethasone sodium phosphate injection of through the round window membrane, intratympanic dexamethasone sodium phosphate injection through the tympanic membrane

DRUG

intratympanic dexamethasone injection

intratympanic dexamethasone sodium phosphate injection (10mg/ml) through tympanic membrane,once every other day, for a total of 4 injections.

Trial Locations (1)

200031

Fenyang Road 83, Shanghai

All Listed Sponsors
collaborator

Shanghai Zhongshan Hospital

OTHER

collaborator

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

OTHER

lead

Eye & ENT Hospital of Fudan University

OTHER